Sonnet BioTherapeutics Holdings, Inc. Common Stock

SONN

...

SONN: Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Show SONN Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of SONN by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by SONN's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on SONN's company Twitter account

WallStreetBets

Number of mentions of SONN in WallStreetBets Daily Discussion

SONN News

Recent insights relating to SONN

CNBC Recommendations

Recent picks made for SONN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SONN

Corporate Flights

Flights by private jets registered to SONN